February 8, 2017 / 2:48 AM / 8 months ago

BRIEF-Jiangsu Hengrui Medicine passes FDA approval

Feb 8 (Reuters) - Jiangsu Hengrui Medicine Co Ltd :

* Says co received approval for its Cisatracurium Besylate injection from U.S Food and Drug Administration

* The company will be able to manufacture and sell its injection in the United States after receiving the FDA approval

Source text in Chinese: goo.gl/y7H6u8

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below